2018
DOI: 10.1161/atvbaha.118.311219
|View full text |Cite
|
Sign up to set email alerts
|

Association of Circulating Chemerin With Subclinical Parameters of Atherosclerosis

Abstract: Supplemental Digital Content is available in the text.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
18
3

Year Published

2018
2018
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 21 publications
(23 citation statements)
references
References 54 publications
2
18
3
Order By: Relevance
“…BMI was the only variable that correlated with chemerin and there was no significant difference in the BMI between the two groups. Recently, several studies have reported that elevated circulating chemerin levels correlate with endothelial dysfunction and can be a biomarker of subclinical atherosclerosis (42)(43)(44). However, in our study, no such relationship between the chemerin levels, quantitative IMT, and arterial stiffness was observed.…”
Section: Discussioncontrasting
confidence: 87%
“…BMI was the only variable that correlated with chemerin and there was no significant difference in the BMI between the two groups. Recently, several studies have reported that elevated circulating chemerin levels correlate with endothelial dysfunction and can be a biomarker of subclinical atherosclerosis (42)(43)(44). However, in our study, no such relationship between the chemerin levels, quantitative IMT, and arterial stiffness was observed.…”
Section: Discussioncontrasting
confidence: 87%
“…Staining of plaques from ApoE−/− mice showed that chemerin increased the lipid content in the plaques and reduced the collagen content, thus increasing the possibility of plaque rupture. In a previous clinical study, chemerin levels were elevated in patients with coronary heart disease and were associated with the number of unstable plaques and the number of coronary lesions [24,38], and the results of this study are in accordance with those findings. In this study, all lipid parameters in ApoE−/− mice were significantly higher than those in WT mice, which is consistent with the genetic characteristics of the model animals.…”
Section: Discussionsupporting
confidence: 91%
“…Chemerin, which is considered an adipokine, was first identified in 2007. Recently, chemerin has been shown to be closely related to inflammation, metabolic syndrome and cardiovascular diseases [ 24 ]. Several studies have concluded that chemerin can be considered a marker of a high atherosclerotic risk [ 25 , 26 ]; however, the specific mechanism of chemerin in AS development has not yet been clarified.…”
Section: Discussionmentioning
confidence: 99%
“…These suggest that chemerin is an adipokine whose secretion can be altered by exercise-induced adiposity reduction. Chemerin is generally elevated in T2DM patients 33,34 , especially in older T2DM patients 41 . Moreover, chemerin was suggested to be a better measure for insulin sensitivity than HOMA-IR in normoglycemic subjects 10 .…”
Section: Discussionmentioning
confidence: 99%